Literature DB >> 9052711

Brain infarction and the clinical expression of Alzheimer disease. The Nun Study.

D A Snowdon1, L H Greiner, J A Mortimer, K P Riley, P A Greiner, W R Markesbery.   

Abstract

OBJECTIVE: To determine the relationship of brain infarction to the clinical expression of Alzheimer disease (AD).
DESIGN: Cognitive function and the prevalence of dementia were determined for participants in the Nun Study who later died. At autopsy, lacunar and larger brain infarcts were identified, and senile plaques and neurofibrillary tangles in the neocortex were quantitated. Participants with abundant senile plaques and some neurofibrillary tangles in the neocortex were classified as having met the neuropathologic criteria for AD.
SETTING: Convents in the Midwestern, Eastern, and Southern United States. PARTICIPANTS: A total of 102 college-educated women aged 76 to 100 years. MAIN OUTCOME MEASURES: Cognitive function assessed by standard tests and dementia and AD assessed by clinical and neuropathologic criteria.
RESULTS: Among 61 participants who met the neuropathologic criteria for AD, those with brain infarcts had poorer cognitive function and a higher prevalence of dementia than those without infarcts. Participants with lacunar infarcts in the basal ganglia, thalamus, or deep white matter had an especially high prevalence of dementia, compared with those without infarcts (the odds ratio [OR] for dementia was 20.7, 95% confidence interval [95% CI], 1.5-288.0). Fewer neuropathologic lesions of AD appeared to result in dementia in those with lacunar infarcts in the basal ganglia, thalamus, or deep white matter than in those without infarcts. In contrast, among 41 participants who did not meet the neuropathologic criteria for AD, brain infarcts were only weakly associated with poor cognitive function and dementia. Among all 102 participants, atherosclerosis of the circle of Willis was strongly associated with lacunar and large brain infarcts.
CONCLUSION: These findings suggest that cerebrovascular disease may play an important role in determining the presence and severity of the clinical symptoms of AD.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9052711

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  583 in total

Review 1.  The burden of dementia. A medical and research perspective.

Authors:  P Antuono; J Beyer
Journal:  Theor Med Bioeth       Date:  1999-01

Review 2.  Canadian Consensus Conference on Dementia: a physician's guide to using the recommendations.

Authors:  C J Patterson; S Gauthier; H Bergman; C A Cohen; J W Feightner; H Feldman; D B Hogan
Journal:  CMAJ       Date:  1999-06-15       Impact factor: 8.262

3.  Chronic overproduction of transforming growth factor-beta1 by astrocytes promotes Alzheimer's disease-like microvascular degeneration in transgenic mice.

Authors:  T Wyss-Coray; C Lin; D A Sanan; L Mucke; E Masliah
Journal:  Am J Pathol       Date:  2000-01       Impact factor: 4.307

4.  Influence of leisure activity on the incidence of Alzheimer's disease.

Authors:  N Scarmeas; G Levy; M X Tang; J Manly; Y Stern
Journal:  Neurology       Date:  2001-12-26       Impact factor: 9.910

5.  Riluzole for motor neurone disease. More trials are needed.

Authors:  J Sandercock; A Burls; C Hyde; A Fry-Smith; P Barton; S Bryan; A Stewart
Journal:  BMJ       Date:  2001-05-26

6.  The angiotensin-converting enzyme gene as a possible risk or protective factor in Alzheimer's disease.

Authors:  T V Shcherbatykh; S A Kiryanov; G I Korovaitseva; N D Selezneva; N I Voskresenskaya; V E Golimbet; L Farrer; S I Gavrilova; E I Rogaev
Journal:  Neurosci Behav Physiol       Date:  2001 Mar-Apr

7.  Issues of clinical trial design and data interpretations in hypertension.

Authors:  L H Kuller
Journal:  Curr Hypertens Rep       Date:  1999-08       Impact factor: 5.369

Review 8.  Patterns of compensation and vulnerability in normal subjects at risk of Alzheimer's disease.

Authors:  Oscar L Lopez; James T Becker; Lewis H Kuller
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

Review 9.  Getting to the Heart of Alzheimer Disease.

Authors:  Joshua M Tublin; Jeremy M Adelstein; Federica Del Monte; Colin K Combs; Loren E Wold
Journal:  Circ Res       Date:  2019-01-04       Impact factor: 17.367

10.  Chemical hypoxia facilitates alternative splicing of EAAT2 in presymptomatic APP23 transgenic mice.

Authors:  Christoph Münch; Bing-gen Zhu; Andreas Mink; Ulrich Seefried; Matthias W Riepe; Albert C Ludolph; Thomas Meyer
Journal:  Neurochem Res       Date:  2007-11-13       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.